Hitachi , Government of Saskatchewan Sign Development Agreement

Hitachi has finalized an agreement with the government of Saskatchewan, Canada for the research and development of nuclear medicine technology, as well as a deal with Hitachi-GE Nuclear Energy, GE Hitachi Nuclear Energy Americas, and Global Nuclear Fuel -- Americas to explore the potential collaboration on future nuclear research and design projects, among them nuclear safety, uranium recovery, and the design of small modular reactor technologies. Under terms of the two agreements, the government of Saskatchewan and four other entities will fund $10 million Canadian ($10.2 million U.S.) to facilitate and support research collaborations in nuclear medicine, materials science, nuclear safety, and small reactor design. The Saskatchewan government earlier this year spent $30 million ($30.6 million U.S.) to establish a new center for research in nuclear medicine and materials science and $17 million ($17.3 million U.S.) to create a Centre for Innovation in Cyclotron Science. Additional investments encompassed $12 million ($12.2 million U.S.) for the support of innovative research in the production of medical isotopes and $10.1 million ($10.3 million U.S.) for the development of Saskatchewan's first proton beam therapy/PET facility for the diagnosis and treatment of cancer and heart disease at the University of Saskatchewan.
Julie Ritzer Ross,

Contributor

Around the web

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.